绥美凯上市价格

In January 2018, ViiV Healthcare, a joint venture of the British multinational pharmaceutical company GlaxoSmithKline (GSK), officially launched its innovative AIDS treatment drug on the Chinese market. So what is the price of Suimeikai?

Price of Suimeikan: It is understood that the price of Suimeikan in China is 2880$/box. Since Suimeikai is an imported original drug in China, it is very expensive and most patients cannot afford it. Therefore, many patients choose Suimeikai, which is launched in India. Suimeikai, produced by the Indian company Emcure, comes in a box of 30 tablets and sells for about RMB 1,000. The price cannot be determined due to the floating exchange rate. Please consult Medical Travel for the specific price.

Patients can choose different versions of Suimeikai according to their own conditions!

Trimax is currently the only three-in-one compound drug containing dolutegravir (DTG), which integrates treatment drugs for different stages of viral infection into the same tablet. Patients only need to take one drug to achieve the effect of combined medication. The drug has been approved for marketing in 50 countries and regions, and has been recommended by many authoritative academic institutions and authoritative guidelines in Europe and the United States as the first-line first-line treatment for patients with HIV infection.

Suimeike preparation contains three antiviral drugs. One preparation is a complete treatment plan. One tablet per day can achieve the effect of cocktail therapy without food restrictions. For the treatment of HIV infection in adults and children over 12 years of age weighing more than 40 kg. Abacavir and lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs); dolutegravir is an integrase inhibitor (INIs).

Existing research shows that one year (48 weeks) after HIV infection treatment, 93% of infected people's viral load becomes negative.

Recommended related hot articles: /newsDetail/71963.html